1 魏雨晴,吕镗烽,刘红兵,等.PD-L1作为PD-1靶向药物治疗非小细胞肺癌疗效预测生物标志的意义及其局限性[J].转化医学电子杂志,2018,5(2):40-44.
2 WangA,WangHY,LiuY,et al.The prognostic value of PD-L1 expression for non-small cell lung cancer patients:a meta-analysis[J].Eur J Surg Oncol,2015,41(4):450-456.
3 陈海瑞,李文才,陈天东,等.原发性肺腺癌组织亚型及预后[J].河南医学研究,2017,26(18):3271-3273.
4 WarthA,MuleyT,MeisterM,et al.The novel histologic international association for the study of lung cancer/American thoracic society/European respiratory society classification system of lung adenocarcinoma is a stage independent predictor of survival[J].J Clin Oncol,2012,30(13):1438-1446.
5 杜海磊,车嘉铭,朱良纲,等.病理T1期浸润性肺腺癌不同病理亚型的临床特征及其预后分析[J].诊断学理论与实践,2018,17(1):82-86.
6 曹玉娟,王德林,刘承伟,等.肺腺癌新分类在预测Ⅰb期非小细胞肺癌预后中的价值[J].肿瘤学杂志,2014,20(6):448-451.
7 田璇,孙蕾娜,王静,等.最新国际肺腺癌分类方法回顾性分析具有细支气管肺泡癌特征的肺腺癌209例[J].中国肿瘤临床,2013,40(8):475-478.
8 StrandTE,RostadH,Str?mEH,et al.The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung[J].Diagn Pathol,2015,10(1):94.
9 LuoJ,HuangQ,WangR,et al.Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB[J].J Cancer Res Clin Oncol,2016,142(9):2031-2040.
10 杨欣,林冬梅.2015版WHO肺癌组织学分类变化及其临床意义[J].中国肺癌杂志,2016,19(6):332-336.
11 朱萌,孙武刚.不同病理类型Ⅰ期肺腺癌患者的生存状况研究[J].中国医药科学,2018,8(9):200-203.
12 SongZ,ZhuH,GuoZ,et al.Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients—Based on a hospital study in China[J].Eur J Surg Oncol,2013,39(11):1262-1268.
13 YoshidaY,Nitadori JI,Shinozaki-UshikuA,et al.Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less:impact on recurrence and clinical predictors[J].Gen Thorac Cardiovasc Surg,2017,65(5):273-279.
14 HoshiR,TsuzukuM,HoraiT,et al.Micropapillary clusters in early-stage lung adenocarcinomas:a distinct cytologic sign of significantly poor prognosis[J].Cancer,2004,102(2):81-86.
15 AminMB,TamboliP,MerchantSH,et al.Micropapillary component in lung adenocarcinoma:a distinctive histologic feature with possible prognostic significance[J].Am J Surg Pathol,2002,26(3):358-364.
16 MiyoshiT,SatohY,OkumuraS,et al.Early-stage lung adenocarcinomas with a micropapillary pattern,a distinct pathologic marker for a significantly poor prognosis[J].Am J Surg Pathol,2003,27(1):101-109.
17 HungJJ.Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma[J].J Thorac Dis,2017,9(10):3623-3625.
18 RosaiJ.Rosai&Ackerman外科病理学[M].郑杰,主译.北京:北京大学医学出版社,2014:370-373
19 刘彤华.诊断病理学[M].3版.北京:人民卫生出版社,2013:137-142.
20 WestawayDD,ToonCW,FarzinM,et al.The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma[J].Pathology,2013,45(6):553-558
21 UjiieH,KadotaK,ChaftJE,et al.Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early,Extrathoracic,Multisite Recurrence and of Poor Postrecurrence Survival[J].J Clin Oncol,2015,33(26):2877-2884.
22 TsubokawaN,MimaeT,SasadaS,et al.Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma[J].Eur J Cardiothorac Surg,2016,49(1):293-299.